About BostonGene
BostonGene is a company based in Waltham (United States) founded in 2015. BostonGene has raised $200 million across 2 funding rounds from investors including NEC, Impact Investment Exchange and Japan Industrial Partners. BostonGene offers products and services including BostonGene Tumor Portrait™ Test, Liquid Biopsy, and Immunohistochemistry (IHC) Test. BostonGene operates in a competitive market with competitors including Helix, Syapse, Benchling, BioAge Labs and Ingenuity Systems, among others.
- Headquarter Waltham, United States
- Stage Unicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bostongene Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$200 M (USD)
in 2 rounds
-
Latest Funding Round
$150 M (USD), Series B
Apr 06, 2022
-
Investors
NEC
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BostonGene
BostonGene offers a comprehensive portfolio of products and services, including BostonGene Tumor Portrait™ Test, Liquid Biopsy, and Immunohistochemistry (IHC) Test.
Offers comprehensive molecular profiling for cancer patients
Provides non-invasive testing for tumor analysis
Detects actionable biomarkers in cancer samples
People of BostonGene
Unlock access to complete
Software Development Team
18 people
Sales and Marketing
14 people
Leadership Team
12 people
Product Management Team
7 people
Data Analysis and Operations Team
6 people
Human Resources and Administration
5 people
Senior Team
5 people
Medical Team
4 people
Unlock access to complete
Funding Insights of BostonGene
BostonGene has successfully raised a total of $200M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $150 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BostonGene
BostonGene has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include NEC, Impact Investment Exchange and Japan Industrial Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward women empowerment initiatives.
|
Locked | Locked | Locked | |
|
Japan Industrial Partners is engaged in industrial revitalization and growth.
|
Locked | Locked | Locked | |
|
Cloud-based IT and networking solutions are provided globally.
|
Locked | Locked | Locked |
Investor details for BostonGene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BostonGene
Investment portfolio details for BostonGene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BostonGene
Detailed financials for BostonGene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bostongene Comparisons
Peer comparison for BostonGene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BostonGene
BostonGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Syapse, Benchling, BioAge Labs and Ingenuity Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Developer of precision medicine for the treatment of cancer
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
Detailed competitors of BostonGene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bostongene
Complete news archive for BostonGene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BostonGene
BostonGene was founded in 2015 and raised its 1st funding round 4 years after it was founded.
BostonGene is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
BostonGene is a funded company, having raised a total of $200M across 2 funding rounds to date.
BostonGene was founded in 2015 and is headquartered in Waltham, United States. Operations focus on the healthcare and biotechnology sectors, where a cloud-based platform integrates AI, algorithms, and modern technologies. Molecular profiles of patient tumors are analyzed, combining tumor microenvironment, genetic data, and clinical information. Results are delivered directly to medical professionals through the MF Portrait platform to support oncology decisions.
BostonGene offers BostonGene Tumor Portrait™ Test, Liquid Biopsy, and Immunohistochemistry (IHC) Test.
BostonGene has 3 investors. Key investors include NEC, Impact Investment Exchange, and Japan Industrial Partners.
The valuation of BostonGene is $1B as of Apr 2022.